InvestorsHub Logo
Followers 92
Posts 11879
Boards Moderated 0
Alias Born 06/06/2014

Re: None

Friday, 10/05/2018 9:04:09 PM

Friday, October 05, 2018 9:04:09 PM

Post# of 403964
A couple people have PM'd me asking what I think the stock is going to do. I tell them no one knows, but I have an opinion on what the possibilities are. I'll repeat it publicly. I believe the stock could go up to $1 to $3 dollars by the end of the year, depending on news.

Around $1: We get a B deal with a mid-tier pharma and get some expensive financing for P results, and those results are "good" (efficacy, but not strong). No BTD for B-OM.
BTD: Add $.50
Cheaper financing: Add $.25. $.50 if a strategic investment by the pharma, or if it's a BP (top tier).
Strong P results: Add $1.

But I also remind them that nothing is sure here, including news. The chance of a deal is really good. We've got a term sheet, we need a deal badly, and our management is not stupid. P is a huge wild card, and its efficacy is not a sure bet. The Phase 2A had tantalizing signs, that's all. More of the drug may not have more of an effect. That's just not the given nature of pharmaceuticals unfortunately. We have to see. B-OM BTD is possible, but the FDA can disappoint. They may have serious doubts from the Phase 2 arm that didn't show any improvement and decide that just OK'ing a Phase 3 is appropriate.

Biotech...